Thomas C. Hanff
( out of 13 reviews )

Thomas C. Hanff, MD, MSCE, MPH

Languages spoken: English

Clinical Locations

Primary Location

Veterans Administration Medical Center

500 S Foothill Blvd
Salt Lake City , UT 84148
801-584-1235
Get Directions

Saint Alphonsus Regional Medical Center

1055 N. Curtis Road
Boise , ID 83706
208-367-2121
Get Directions

Cardiovascular Center

Cardiovascular Center
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions
Show 1 more location(s)

University of Utah Hospital

Heart Failure Clinic
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

Dr. Thomas Hanff is an Assistant Professor of Medicine at the University of Utah and the Salt Lake VA Medical Center. Dr. Hanff graduated Summa Cum Laude from the University of California, Los Angeles with a major in Neuroscience and a minor in Public Policy (2008). He received his medical degree and Master of Public Health from the Johns Hopkins University Schools of Medicine and Public Health (2013). He then trained at the University of Pennsylvania where he completed internship and residency in Internal Medicine (2016) and fellowships in Cardiovascular Disease (2019) and Advanced Heart Failure and Transplant Cardiology (2021). He also completed a Master of Science in Clinical Epidemiology while at the University of Pennsylvania (2020). He joined the faculty at the University of Utah, Division of Cardiovascular Medicine in 2021.

Dr. Hanff specializes in the care of patients with advanced heart failure of all types, both in the hospital and in the outpatient setting. He has extensive expertise in the management of patients who require advanced heart failure therapies such as left ventricular assist devices, heart transplantation, or inotropic therapy. He also specializes in the care of patients with acute decompensated heart failure or cardiogenic shock and in the use of temporary mechanical circulatory support devices as a bridge to recovery or more definitive therapy. He strives to practice at the forefront of evidence-based medicine, with personalized therapeutic plans for every patient matched to their underlying illness and goals of care.

Dr. Hanff’s research is motivated by two simple questions: 1) Which patients would benefit from various advanced heart failure therapies and 2) When is the optimal time to offer each therapy to a patient based on their individual characteristics? To answer these questions, Dr. Hanff has developed a research program that couples traditional outcomes research with personalized “omics” approaches, using advanced statistical modeling techniques, bioinformatics, and machine learning. He collaborates with several highly regarded researchers throughout the world and works closely with numerous landmark national and international cohorts. His work has been published in top medical journals including JAMA Cardiology, Circulation Heart Failure, Lancet Respiratory Medicine, the Journal of Heart and Lung Transplantation, JACC: Basic to Translational Science, Hypertension, and Stroke.

Dr. Hanff is board certified in Internal Medicine, Cardiovascular Medicine, and Echocardiography. He is involved with numerous professional societies including the International Society for Heart and Lung Transplantation, the American Heart Association, the Heart Failure Society of America, and the American College of Cardiology, for which he has served on the Clinical Data Standards Task Force.

Specialties

Board Certification

National Board of Echocardiography
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Medical Examiners
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)

Patient Rating

4.9 /5
( out of 13 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Mar 01, 2026
EXTERNAL SITE

Consummate professional who listens to patients as well as instructing them. Not afraid of or threatened by patients eith any degree of medical knowledge (UNBELIEVABLY refreshing).

Nov 26, 2024
EXTERNAL SITE

My first visit and already gain my thrust.

Jul 19, 2024
EXTERNAL SITE

Good care, knowledgeable, he explained things so I could understand them

May 18, 2024
UH HOSPITALS AND CLINICS

Good Guy. Can tell He really enjoys what He does! And just a real Positive Person

May 13, 2024
UH HOSPITALS AND CLINICS

He was very patient and answered all my questions concerning the stress test results.

Mar 18, 2024
EXTERNAL SITE

This provider was very kind, positive and reassuring during my visit. I could not be more appreciative of the care I'm receiving from this doctor.

Feb 06, 2024
UH HOSPITALS AND CLINICS

Dr Hanff is a REAL doctor who doesn't get caught up in the extra fluff that can distract you sometimes, I appreciate his direct responses, kindness, courteousness, and professionalism. Thank you Dr Hanff&supporting U of U staff

Aug 21, 2023
EXTERNAL SITE

Thank you Dr. Hanff, I was concerned that I didn't get to see Dr. Pinzar, but you alleviated my fear and were a wonderful provider. Your care and concern for me as a patient was stellar!!!!

Aug 12, 2023
EXTERNAL SITE

Professional with care Committed to connecting with the patient. Clear on every Option and approach. Committed to improve my heart function overall. You can tell he really cares, very devoted to the care of his patients Healthiest outcome. Communicated with me where I could follow along with what he was saying and I left there with a clear understanding of what was held. My head up high because I walked in there with very little hope. I left with joy in my heart. Smiling, I'm looking forward Now to a better heart function and a Lively, Active Future

Mar 02, 2023
UH HOSPITALS AND CLINICS

I have had problems in the past he just does nothing to help . I am tired of working with him!!!!!

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Thomas Hanff is an Assistant Professor of Medicine at the University of Utah and the Salt Lake VA Medical Center. Dr. Hanff graduated Summa Cum Laude from the University of California, Los Angeles with a major in Neuroscience and a minor in Public Policy (2008). He received his medical degree and Master of Public Health from the Johns Hopkins University Schools of Medicine and Public Health (2013). He then trained at the University of Pennsylvania where he completed internship and residency in Internal Medicine (2016) and fellowships in Cardiovascular Disease (2019) and Advanced Heart Failure and Transplant Cardiology (2021). He also completed a Master of Science in Clinical Epidemiology while at the University of Pennsylvania (2020). He joined the faculty at the University of Utah, Division of Cardiovascular Medicine in 2021.

Dr. Hanff specializes in the care of patients with advanced heart failure of all types, both in the hospital and in the outpatient setting. He has extensive expertise in the management of patients who require advanced heart failure therapies such as left ventricular assist devices, heart transplantation, or inotropic therapy. He also specializes in the care of patients with acute decompensated heart failure or cardiogenic shock and in the use of temporary mechanical circulatory support devices as a bridge to recovery or more definitive therapy. He strives to practice at the forefront of evidence-based medicine, with personalized therapeutic plans for every patient matched to their underlying illness and goals of care.

Dr. Hanff’s research is motivated by two simple questions: 1) Which patients would benefit from various advanced heart failure therapies and 2) When is the optimal time to offer each therapy to a patient based on their individual characteristics? To answer these questions, Dr. Hanff has developed a research program that couples traditional outcomes research with personalized “omics” approaches, using advanced statistical modeling techniques, bioinformatics, and machine learning. He collaborates with several highly regarded researchers throughout the world and works closely with numerous landmark national and international cohorts. His work has been published in top medical journals including JAMA Cardiology, Circulation Heart Failure, Lancet Respiratory Medicine, the Journal of Heart and Lung Transplantation, JACC: Basic to Translational Science, Hypertension, and Stroke.

Dr. Hanff is board certified in Internal Medicine, Cardiovascular Medicine, and Echocardiography. He is involved with numerous professional societies including the International Society for Heart and Lung Transplantation, the American Heart Association, the Heart Failure Society of America, and the American College of Cardiology, for which he has served on the Clinical Data Standards Task Force.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Cardiovascular Medicine
Board Certification
National Board of Echocardiography
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Medical Examiners
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)

Education history

Undergraduate Neuroscience - University of California, Los Angeles B.S.
Professional Medical Medicine - Johns Hopkins University School of Medicine M.D.
Graduate Training Master of Public Health - Johns Hopkins Bloomberg School of Public Health M.P.H.
Internship Medicine - University of Pennsylvania Intern
Residency Medicine - University of Pennsylvania Resident
Fellowship Cardiology - University of Pennsylvania Fellow
Graduate Training Clinical Epidemiology - University of Pennsylvania Department of Biostatistics, Epidemiology, and Informatics M.S.C.E
Fellowship Advanced Heart Failure and Transplant Cardiology - University of Pennsylvania Fellow

Selected Publications

Journal Article

  1. Sideris K, Bunsawat K, Brinker L, Braun E, Iacovelli J, Chen A, Simmons JM, Zhao J, Carter S, Tseliou E, Kyriakopoulos CP, Hanff TC, Florido R, Brann AM, Fang JC, Greene T, Wray DW, Stehlik (2026). The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study. The American journal of cardiology, 266, 104-111.
  2. Kyriakopoulos CP, Sideris K, Kyriakoulis I, Taleb I, Maneta E, Zhang C, Tseliou E, Carter S, Florido R, Welt FG, Stehlik J, Selzman CH, Fang JC, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2026). Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock. European heart journal open, 6(1), oeag015.
  3. Hockstein MA, Horns JJ, Hanff T, Taleb I, Selzman C, Drakos S, Nelson R, Tonna J (2026). Hospital Costs Associated With Mechanical Left Ventricular Unloading Devices During VA ECMO for Adult Cardiogenic Shock. Artificial organs,
  4. Kanwar MK, Nayak A, Schlöglhofer T, Bernhardt AM, Hanff T, Muthiah K, Granegger M, Molina EJ, Uriel N, Netuka I, Mehra MR, Rogers (2026). The future of durable mechanical circulatory support devices: Emerging innovations. The Journal of heart and lung transplantation,
  5. Dunlay SM, Pinney SP, Lala A, Stewart GC, McIlvennan C, Wong RP, Morris AA, Pagani FD, Allen LA, Breathett K, Cogswell R, Colvin MM, Cowger JA, Drakos SG, Gelfman LP, Kanwar MK, Kiernan MS, Kittleson MM, Lewis EF, Moazami N, Ogunniyi MO, Pandey A, Rogers JG, Schumacher KR, Slaughter MS, Tedford RJ, Teuteberg J, Valantine HA, DeFilippis EM, Dixon DD, Golbus JR, Gulati G, Hanff TC, Hsiao S, Lewsey SC, McCormick AD, Nayak A, Fenton KN, Longacre LS, Shanbhag SM, Taddei-Peters WC, Stevenson L (2025). Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. JAMA cardiology, 10(4), 391-398.
  6. Kyriakopoulos CP, Taleb I, Sideris K, Maneta E, Hamouche R, Tseliou E, Krauspe E, Selko S, Carter S, Jones TL, Zhang C, Presson AP, Dranow E, Geer L, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2025). Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a Hub. Journal of the American Heart Association, 14(4), e035464.
  7. Brinker L, Sideris K, Wei G, Singh R, Nevers MR, Hartsell SE, Sarwal A, Kyriakopoulos CP, Tseliou E, Benes J, Melenovsky V, Drakos SG, Hanff TC, Carter S, Fang JC, Cho M, Beddhu S, Stehlik (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC. Heart failure, 13(8), 102520.
  8. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Tseliou E, Aadland J, Baird AS, Bonios MJ, Nelson M, Dranow E, Goodwin ML, Hanff TC, Carter S, Selzman CH, Stehlik J, Wever-Pinzon O, Ramakrishna S, Tumarkin E, Drakos S (2025). Left Atrial Reverse Remodeling in Patients Supported With Durable Left Ventricular Assist Devices and Clinical Implications. Circulation. Heart failure, 18(7), e012807.
  9. Scott M, Kyriakopoulos CP, Sheffield E, Krauspe E, Sideris K, Taleb I, Maneta E, Tseliou E, Selko S, Hamouche R, Aadland J, Carter SJ, Jones TL, Ou Z, Presson AP, Selzman CH, Tonna JE, Hanff TC, Drakos S (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. The Canadian journal of cardiology, 41(10), 2053-2063.
  10. Nayak A, Cascino TM, DeFilippis EM, Hanff TC, Cevasco M, Keenan J, Zhen-Yu Tong M, Kilic A, Koehl D, Cantor R, Jacobs JP, Habib RH, Kirklin JK, Cowger JA, Pagani FD, Silvestry S (2025). The Society of Thoracic Surgeons Intermacs 2025 Annual Report: Focus on Outcomes in Older Adults. The Annals of thoracic surgery,
  11. Bansal N, Maneta E, Zelnick L, Kyriakopoulos CP, Beddhu S, Hartsell S, Stempien-Otero A, Welt F, Tseliou E, Hanff T, Nelson M, Sideris K, Kyriakoulis I, Goldstein J, Mendenhall T, Deol A, Alharethi R, Selzman C, Drakos (2025). Association of Kidney Function With Myocardial Recovery and Adverse Events Following Left Ventricular Assist Device Circulatory Support. Journal of the American Heart Association, 14(24), e043498.
  12. Taleb I, Kyriakopoulos CP, Fong R, Ijaz N, Demertzis Z, Sideris K, Wever-Pinzon O, Koliopoulou AG, Bonios MJ, Shad R, Peruri A, Hanff TC, Dranow E, Giannouchos TV, Krauspe E, Zakka C, Tang DG, Nemeh HW, Stehlik J, Fang JC, Selzman CH, Alharethi R, Caine WT, Cowger JA, Hiesinger W, Shah P, Drakos S (2024). Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF Score. JAMA cardiology, 9(3), 272-282.
  13. Sideris K, Weir CR, Schmalfuss C, Hanson H, Pipke M, Tseng PH, Lewis N, Sallam K, Bozkurt B, Hanff T, Schofield R, Larimer K, Kyriakopoulos CP, Taleb I, Brinker L, Curry T, Knecht C, Butler JM, Stehlik (2024). Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial. Journal of the American Medical Informatics Association, 31(4), 919-928.
  14. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos S (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation. Heart failure, 17(11), e011709.
  15. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Hamouche R, Tseliou E, Zhang C, Presson AP, Dranow E, Shah KS, Jones TL, Fang JC, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2024). Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock. Circulation. Heart failure, 17(9), e011358.
  16. Chavez MA, Anderson M, Kyriakopoulos CP, Scott M, Dranow E, Maneta E, Hamouche R, Taleb I, Leon J, Kogelschatz B, Goldstein J, Billia F, Baran DA, Tehrani B, Goodwin M, Selzman CH, Tonna JE, Fang JC, Drakos SG, Hanff T (2024). Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circulation. Heart failure, 17(9), e011827.
  17. Kyriakopoulos CP, Taleb I, Tseliou E, Sideris K, Hamouche R, Maneta E, Nelson M, Krauspe E, Selko S, Visker JR, Dranow E, Goodwin ML, Alharethi R, Wever-Pinzon O, Fang JC, Stehlik J, Selzman CH, Hanff TC, Drakos S (2024). Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support. Journal of the American Heart Association, 13(14), e032936.
  18. Yin MY, Maneta E, Kyriakopoulos CP, Michaels AT, Genovese LD, Indaram MB, Wever-Pinzon O, Singh R, Tseliou E, Taleb I, Nemeh HW, Alharethi R, Tang DG, Goldstein J, Hanff TC, Selzman CH, Cowger J, Kanwar M, Shah P, Drakos S (2024). Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices. ASAIO journal (American Society for Artificial Internal Organs, 70(12), 1060-1066.
  19. Kyriakopoulos CP, Selzman CH, Giannouchos TV, Mylavarapu R, Sideris K, Elmer A, Vance N, Hanff TC, Kagawa H, Stehlik J, Drakos SG, Goodwin M (2024). Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices. Journal of clinical medicine, 13(10),
  20. Sideris K, Lázár-Molnár E, Kyriakopoulos CP, Taleb I, Hurst D, Ugolini S, Selzman CH, Brinker L, Drakos SG, Tonna JE, Geer L, Goodwin ML, Wever-Pinzon O, Hanff TC, Fang JC, Carter S, Stehlik (2024). Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization. Clinical transplantation, 38(5), e15330.
  21. Goodwin ML, Nickel IC, Li H, Kagawa H, Kyriakopoulos CP, Hanff TC, Stehlik J, Drakos SG, Selzman C (2024). Direct Procurement with Machine Perfusion and Normothermic Regional Perfusion in Donation after Circulatory Death Heart Transplantation. The Journal of thoracic and cardiovascular surgery, 170(1), 256-265.e6.
  22. Agarwal A, Beddhu S, Boucher R, Rao V, Ramkumar N, Rodan AR, Fang J, Wynne BM, Drakos SG, Hanff T, Cheung AK, Fang J (2024). Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study. Physiological reports, 12(9), e16033.
  23. Visker JR, Brintz BJ, Kyriakopoulos CP, Hillas Y, Taleb I, Badolia R, Shankar TS, Amrute JM, Ling J, Hamouche R, Tseliou E, Navankasattusas S, Wever-Pinzon O, Ducker GS, Holland WL, Summers SA, Koenig SC, Hanff TC, Lavine KJ, Murali S, Bailey S, Alharethi R, Selzman CH, Shah P, Slaughter MS, Kanwar MK, Drakos S (2024). Integrating molecular and clinical variables to predict myocardial recovery. bioRxiv,
  24. Alba AC, Kirklin JK, Cantor RS, Deng L, Ross HJ, Jacobs JP, Rao V, Hanff TC, Stehlik (2023). The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis. The Journal of heart and lung transplantation, 42(11), 1587-1596.
  25. Dalia T, Pothuru S, Chan WC, Mehta H, Goyal A, Farhoud H, Boda I, Malhotra A, Vidic A, Rali AS, Hanff TC, Gupta K, Fang JC, Shah (2023). Trends and Outcomes of Cardiogenic Shock in Patients With End-Stage Renal Disease: Insights From USRDS Database. Circulation. Heart failure, 16(8), e010462.
  26. Kyriakopoulos CP, Horne BD, Sideris K, Taleb I, Griffin RJ, Sheffield E, Alharethi R, Hanff TC, Stehlik J, Selzman CH, Drakos S (2023). Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support. The Journal of heart and lung transplantation, 42(7), 853-858.
  27. Peters CJ, Zhang RS, Vidula MK, Giri J, Atluri P, Acker MA, Bermúdez CA, Levin A, Urgo K, Wald J, Mazurek JA, Hanff TC, Goldberg LR, Jagasia D, Birati E (2023). Durable Left Ventricular Assist Device Outflow Graft Obstructions: Clinical Characteristics and Outcomes. Journal of clinical medicine, 12(6),
  28. Hanff TC, Browne A, Dickey J, Gaines H, Harhay MO, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik (2023). Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. The Journal of heart and lung transplantation, 42(3), 368-376.
  29. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424.
  30. Schurr JW, Sigal I, Usman A, Patel P, Lefebvre B, Kurcik K, Atluri P, Acker M, Bermudez C, Rame JE, Hanff T, Cevasco M, Wald (2023). Effect of Anesthesia Induction on Cardiac Hemodynamics in Patients Undergoing Durable Left Ventricular Assist Device Implantation: The EACH-LVAD Study. ASAIO journal (American Society for Artificial Internal Organs, 69(10), 907-914.
  31. Gard EK, Beale AL, Telles F, Silvestry FE, Hanff T, Hummel SL, Litwin SE, Petrie MC, Shah SJ, Borlaug BA, Burkhoff D, Komtebedde J, Kaye DM, Nanayakkara (2023). Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction. European journal of heart failure, 25(6), 806-814.
  32. Zhang RS, Hanff TC, Zhang Y, Genuardi MV, Peters CJ, Levin A, Molina M, McLean RC, Mazurek JA, Zamani P, Tanna MS, Wald J, Santangeli P, Atluri P, Goldberg LR, Birati E (2023). Chronotropic Incompetence after Heart Transplantation Is Associated with Increased Mortality and Decreased Functional Capacity. Journal of clinical medicine, 12(10),
  33. Hanff TC, Zhang Y, Zhang RS, Genuardi MV, Molina M, McLean RC, Mazurek JA, Tanna MS, Wald JW, Atluri P, Acker MA, Goldberg LR, Zamani P, Birati E (2023). Early Cardiopulmonary Fitness after Heart Transplantation as a Determinant of Post-Transplant Survival. Journal of clinical medicine, 12(1),
  34. Browne A, Gaines H, Alharethi R, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J, Hanff T (2022). Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy Change. Journal of cardiac failure, 29(2), 220-224.
  35. Sadeh B, Ugolini S, Pinzon OW, Potapov EV, Selzman CH, Bader F, Zuckermann AO, Gomez-Mesa JE, Shah KS, Alharethi R, Morejon-Barragan P, Hanff T, Goldraich LA, Farrero M, MacDonald PS, Drakos S, Mehra MR, Stehlik (2022). Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey. Clinical transplantation, 36(7), e14733.
  36. Peters CJ, Hanff TC, Genuardi MV, Zhang R, Domenico C, Atluri P, Mazurek JA, Urgo K, Wald J, Tanna MS, Shore S, Acker MA, Goldberg LR, Margulies KB, Birati E (2022). Safety and Effectiveness of Intravenous Iron Therapy in Patients Supported by Durable Left Ventricular Assist Devices. Journal of clinical medicine, 11(13),
  37. Shore S, Hanff TC, Mazurek JA, Fox A, Tanna MS, Grandin EW, Zhang R, Wald J, Peters C, Acker MA, Atluri P, Rame JE, Goldberg LR, Jessup M, Margulies KB, Birati E (2022). The Anemia Stress Index-Anemia, Transfusions, and Mortality in Patients with Continuous Flow Ventricular Assist Devices. Journal of clinical medicine, 11(15),
  38. Cohen JB, Mitchell GF, Gill D, Burgess S, Rahman M, Hanff TC, Ramachandran VS, Mutalik KM, Townsend RR, Chirinos J (2022). Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank. Circulation research, 131(6), 545-554.
  39. Zhang RS, Hanff TC, Peters CJ, Evans PT, Marble J, Rame JE, Atluri P, Urgo K, Tanna MS, Mazurek JA, Acker MA, Cevasco M, Birati EY, Wald J (2022). Left Ventricular Assist Device as a Bridge to Recovery: Single Center Experience of Successful Device Explantation. ASAIO journal (American Society for Artificial Internal Organs, 68(6), 822-828.
  40. Edelson JB, Edwards JJ, Katcoff H, Mondal A, Chen F, Reza N, Hanff TC, Griffis H, Mazurek JA, Wald J, Burstein DS, Atluri P, O'Connor MJ, Goldberg LR, Zamani P, Groeneveld PW, Rossano JW, Lin KY, Birati E (2022). Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk Score. Journal of the American Heart Association, 11(2), e020942.
  41. Genuardi MV, Moss N, Najjar SS, Houston BA, Shore S, Vorovich E, Atluri P, Molina M, Chambers S, Sharkoski T, Hsich E, Estep JD, Owens AT, Alexander KM, Chaudhry SP, Garcia-Cortes R, Molina E, Rodrigo M, Wald MJ, Margulies KB, Hanff TC, Zimmer R, Kilic A, Mclean R, Vidula H, Dodd K, Blumberg EA, Mazurek JA, Goldberg LR, Alvarez-Garcia J, Mancini D, Teuteberg JJ, Tedford RJ, Birati EY (2021). Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant, 40, 926-935.
  42. Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP (2021). Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One, 16(4), e0248080.
  43. Birati EY, Najjar SS, Tedford RJ, Houston BA, Shore S, Vorovich E, Atluri P, Urgo K, Molina M, Chambers S, Escobar N, Hsich E, Estep JD, Alexander KM, Teuteberg JJ, Chaudhry SP, Ravichandran A, DeVore AD, Margulies KB, Hanff TC, Zimmer R, Kilic A, Wald JW, Vidula H, Martens J, Blumberg EA, Mazurek JA, Owens AT, Goldberg LR, Alvarez-Garcia J, Mancini DM, Moss N, Genuardi MV (2021). Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. Circ Heart Fail, 14(4), e007957.
  44. Khatana SAM, Hanff TC, Nathan AS, Dayoub EJ, Grandin EW, Rame JE, Fanaroff AC, Giri J, Groeneveld P (2021). Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry. Circulation. Heart failure, 14(5), e008277.
  45. Edelson JB, Edwards JJ, Katcoff H, Mondal A, Reza N, Hanff TC, Griffis H, Mazurek JA, Wald J, Owens AT, Burstein DS, Atluri P, O'Connor MJ, Goldberg LR, Zamani P, Groeneveld PW, Rossano JW, Lin KY, Birati E (2021). An Increasing Burden of Disease: Emergency Department Visits Among Patients With Ventricular Assist Devices From 2010 to 2017. Journal of the American Heart Association, 10(4), e018035.
  46. Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C, Rodriguez-Mori JE, Renna N, Chang TI, Corrales-Medina V, Andrade-Villanueva JF, Barbagelata A, Cristodulo-Cortez R, Díaz-Cucho OA, Spaak J, Alfonso CE, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-García RJ, Castro-Callirgos CA, González-Hernández LA, Bernales-Salas EF, Coacalla-Guerra JC, Salinas-Herrera CD, Nicolosi L, Basconcel M, Byrd JB, Sharkoski T, Bendezú-Huasasquiche LE, Chittams J, Edmonston DL, Vasquez CR, Chirinos J (2021). Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. The Lancet. Respiratory medicine, 9(3), 275-284.
  47. Hanff TC, Cohen JB, Zhao L, Javaheri A, Zamani P, Prenner SB, Rietzschel E, Jia Y, Walsh A, Maranville J, Wang Z, Adam L, Ramirez-Valle F, Schafer P, Seiffert D, Gordon DA, Cvijic ME, Cappola TP, Chirinos J (2021). Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction. JACC. Basic to translational science, 6(2), 89-99.
  48. Zamani P, Proto EA, Wilson N, Fazelinia H, Ding H, Spruce LA, Davila A Jr, Hanff TC, Mazurek JA, Prenner SB, Desjardins B, Margulies KB, Kelly DP, Arany Z, Doulias PT, Elrod JW, Allen ME, McCormack SE, Schur GM, D'Aquilla K, Kumar D, Thakuri D, Prabhakaran K, Langham MC, Poole DC, Seeholzer SH, Reddy R, Ischiropoulos H, Chirinos J (2021). Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism. ESC heart failure, 8(4), 2698-2712.
  49. Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA (2020). Thrombosis in COVID-19. Am J Hematol, 95(12), 1578-1589.
  50. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM (2020). Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations. Clin Infect Dis, 71(15), 870-874.
  51. Chirinos JA, Cohen JB, Zhao L, Hanff T, Sweitzer N, Fang J, Corrales-Medina V, Anmar R, Morley M, Zamani P, Bhattacharya P, Brandimarto J, Jia Y, Basso MD, Wang Z, Ebert C, Ramirez-Valle F, Schafer PH, Seiffert D, Gordon DA, Cappola T (2020). Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure. Hypertension, 76(5), 1526-1536.
  52. Cohen JB, Hanff TC, Bress AP, South AM (2020). Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. Curr Hypertens Rep, 22(7), 44.
  53. Cohen JB, Hanff TC, Corrales-Medina V, William P, Renna N, Rosado-Santander NR, Rodriguez-Mori JE, Spaak J, Andrade-Villanueva J, Chang TI, Barbagelata A, Alfonso CE, Bernales-Salas E, Coacalla J, Castro-Callirgos CA, Tupayachi-Venero KE, Medina C, Valdivia R, Villavicencio M, Vasquez CR, Harhay MO, Chittams J, Sharkoski T, Byrd JB, Edmonston DL, Sweitzer N, Chirinos JA (2020). Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J Clin Hypertens (Greenwich), 22(10), 1780-1788.
  54. Hanff TC, Harhay MO, Kimmel SE, Molina M, Mazurek JA, Goldberg LR, Birati E (2020). Trends in Mechanical Support Use as a Bridge to Adult Heart Transplant Under New Allocation Rules. JAMA cardiology, 5(6), 728-729.
  55. Shore S, Hanff TC, Mazurek JA, Seigerman M, Zhang R, Grandin EW, Vorovich E, Mather P, Olt C, Howard J, Wald J, Acker MA, Goldberg LR, Atluri P, Margulies KB, Rame JE, Birati E (2020). The effect of transfusion of blood products on ventricular assist device support outcomes. ESC heart failure, 7(6), 3573-3581.
  56. Hanff TC, Kaye DM, Hayward CS, Post MC, Malek F, Hasenfuß G, Gustafsson F, Burkhoff D, Shah SJ, Litwin SE, Kahwash R, Hummel SL, Borlaug BA, Solomon SD, Lam CSP, Komtebedde J, Silvestry FE, REDUCE LAP-HF study investigators, and research staff. (2019). Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial). Am J Cardiol, 124(12), 1912-1917.
  57. Birati EY, Hanff TC, Maldonado D, Grandin EW, Kennel PJ, Mazurek JA, Vorovich E, Seigerman M, Howard JLL, Acker MA, Naka Y, Wald J, Goldberg LR, Jessup M, Atluri P, Margulies KB, Schulze PC, Rame J (2018). Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score. Journal of the American Heart Association, 7(6),
  58. Gopal DJ, Hanff TC, Mazurek JA, Grandin WE, Howard J, Forde-McLean R, Wald J, King K, Acker MA, Goldberg LR, Jessup M, Atluri P, Margulies KB, Rame EJ, Birati EY (2017). Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients With Severe Heart Failure. Am J Cardiol, 120(11), 2003-2007.
  59. Birati EY, Mathelier H, Molina M, Hanff TC, Mazurek JA, Atluri P, Acker MA, Rame JE, Margulies KB, Goldberg LR, Jessup M (2016). Comparison of Causes of Death After Heart Transplantation in Patients With Left Ventricular Ejection Fractions ¿35% Versus >35. Am J Cardiol, 117(8), 1322-6.
  60. Minor TR, Hanff TC (2015). Adenosine signaling in reserpine-induced depression in rats. Behav Brain Res, 286, 184-91.
  61. Golbus JR, Manly DA, Wonneberger KA, Hanff TC, Murphy KM, Wang DS, McKee SG, Bellini (2015). Implementation of a Novel, Resident-Led, Nocturnal Curriculum. Journal of graduate medical education, 7(3), 417-21.
  62. Hanff TC, Sharrett AR, Mosley TH, Shibata D, Knopman DS, Klein R, Klein BE, Gottesman RF (2014). Retinal microvascular abnormalities predict progression of brain microvascular disease: an atherosclerosis risk in communities magnetic resonance imaging study. Stroke, 45(4), 1012-7.
  63. Gill RS, Hambridge HL, Schneider EB, Hanff T, Tamargo RJ, Nyquist (2013). Falling temperature and colder weather are associated with an increased risk of aneurysmal subarachnoid hemorrhage. World neurosurgery, 79(1), 136-42.
  64. Hanff TC, Furst SJ, Minor TR (2010). Biochemical and anatomical substrates of depression and sickness behavior. Isr J Psychiatry Relat Sci, 47(1), 64-71.

Review

  1. Kyriakoulis I, Nickel I, Kanwar MK, Hanff TC, Stehlik J, Selzman CH, Drakos S (2026). International Utah Cardiac Recovery Symposium (U-CARS) 2025: Clinical Science Proceedings. Heart failure reviews, 31(1),
  2. Blumer V, Hanff TC, Gage A, Schrage B, Kanwar M (2025). Cardiogenic Shock Teams: Past, Present, and Future Directions. Circulation. Heart failure, e011630.
  3. Lim HS, González-Costello J, Belohlavek J, Zweck E, Blumer V, Schrage B, Hanff T (2024). Hemodynamic management of cardiogenic shock in the intensive care unit. The Journal of heart and lung transplantation,
  4. Barnett CF, Brusca SB, Hanff TC, Blumer V, Kalif A, Kanwar (2023). Management of Cardiogenic Shock Unrelated to Acute Myocardial Infarction. The Canadian journal of cardiology, 39(4), 406-419.
  5. Tehrani BN, Drakos SG, Billia F, Batchelor WB, Luk A, Stelling K, Tonna J, Rosner C, Hanff T, Rao V, Brozzi NA, Baran D (2022). The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design. The Canadian journal of cardiology, 38(8), 1286-1295.
  6. Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, Muser D, Ferrari VA, Nazarian S, Santangeli P, Deo R, Cooper LT Jr, Mohiddin SA, Chahal CA (2022). The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury. JACC. Basic to translational science, 7(3), 294-308.

Conference Proceedings

  1. Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, Ensminger S, Hernandez-Montfort J, Sinha SS, Vorovich E, Proudfoot A, Lim HS, Blumer V, Jennings DL, Reshad Garan A, Renedo MF, Hanff TC, Baran DA, Consensus Conference participant (2024). Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. The Journal of heart and lung transplantation, 43(2), 189-203.

Editorial

  1. Hanff TC, Johnson MR, Stehlik (2024). Heart Transplant Performance Metrics: Separating Signal From Noise. JACC. Heart failure, 12(7), 1284-1287.
  2. Dunlay SM, Hanff TC, Drakos S (2024). Therapeutic Options in Ambulatory Advanced Heart Failure: A Moving Target. JACC. Heart failure, 12(10), 1747-1749.
  3. Hanff TC, Kemeyou (2022). Impaired Forced Expiratory Volume Across the Heart Failure Spectrum. Chest, 161(1), 11-12.
  4. Stehlik J, Cherikh WS, Hanff T (2022). The HeartMate 3 Risk Score: Updating LVAD Risk Assessment for the Current Era. JACC. Heart failure, 10(12), 960-962.
  5. Siripanthong B, Hanff TC, Levin MG, Vidula MK, Khanji MY, Nazarian S, Chahal CA (2021). Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure. Future cardiology, 17(1), 3-6.
  6. Hanff TC, Birati EY (2019). Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support. Curr Heart Fail Rep, 16(5), 168-179.

Letter

  1. Edwards JJ, Edelson JB, Katcoff H, Mondal A, Lefkowitz D, Reza N, Hanff TC, Griffis H, Mazurek JA, Wald J, Owens AT, Wittlieb-Weber CA, Burstein DS, Atluri P, O'Connor MJ, Goldberg LR, Zamani P, Groeneveld PW, Rossano JW, Lin KY, Birati EY (2021). Mental health disorders and emergency resource use and outcomes in ventricular assist device supported patients. [Letter to the editor]. Am Heart J, 240, 11-15.
  2. Hanff TC, Goldberg LR, Birati E (2021). Venoarterial Extracorporeal Membrane Oxygenation to Heart Transplant-An Inflamed Bridge?-Reply. JAMA cardiology, 6(3), 362-363.
  3. Hanff TC, Harhay MO, Kimmel SE, Birati EY, Acker MA (2020). Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States. [Letter to the editor]. J Heart Lung Transplant, 39(7), 725-726.
  4. Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM (2020). Reply to Tedeschi et al. [Letter to the editor]. Clin Infect Dis, 71(15), 901.
  5. Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA (2020). Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". [Letter to the editor]. Circ Res, 126(12), e140-e141.

Other

  1. Baran DA, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, Ensminger S, Hernandez-Montfort J, Sinha SS, Vorovich E, Proudfoot A, Lim HS, Blumer V, Jennings DL, Reshad Garan A, Renedo MF, Hanff TC, Kanwar MK, Consensus Conference participants/collaborator (2024). Consensus statements from the International Society for Heart and Lung Transplantation consensus conference: Heart failure-related cardiogenic shock. The Journal of heart and lung transplantation, 43(2), 204-216.